HCPCS Level II code A2008 designates theragenesis billed per square centimeter as an add-on, separately reported in conjunction with a primary procedure. The code captures incremental therapeutic tissue generation or wound augmentation efforts that are quantified by area rather than by procedure episode. Nationally, accurate use of A2008 matters for correct clinical documentation, consistent claims submission, and appropriate recognition of additional resource use in complex wound care and reconstructive procedures.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise explanation of the code’s clinical intent and service context, an outline of typical sites of service, and a roadmap of coverage and billing considerations commonly examined by payers. The publication provides benchmarks and coding practice patterns where available, summarizes policy elements that affect add-on area-based services, and situates A2008 within clinical workflows for wound care and tissue regeneration.

This summary is intended for coding professionals, billing administrators, and clinical leaders seeking a compact national overview of HCPCS Level II code A2008, how it is used alongside primary procedures, and the payer landscape that shapes reimbursement and documentation expectations.